Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment

Releasing Hormone ◽

Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

Urology ◽

10.1016/0090-4295(95)80028-x ◽

1995 ◽

Vol 45 (2) ◽

pp. 329-331 ◽

Cited By ~ 17

Author(s):

Karl G. Braslis ◽

Richard C. David ◽

Eustos Nelson ◽

Francisco Civantos ◽

Mark S. Soloway

Keyword(s):

Squamous Cell Carcinoma ◽

Luteinizing Hormone ◽

Cell Carcinoma ◽

Squamous Cell ◽

Releasing Hormone ◽

Carcinoma Of The Prostate

Analogs of Luteinizing Hormone-releasing Hormone in Benign Prostatic Hyperplasia and Advanced Renal Cell Carcinoma

Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance ◽

10.1007/978-88-470-2085-6_2 ◽

2003 ◽

pp. 21-28

Author(s):

A. M. Comaru-Schally

Keyword(s):

Renal Cell Carcinoma ◽

Benign Prostatic Hyperplasia ◽

Luteinizing Hormone ◽

Cell Carcinoma ◽

Renal Cell ◽

Prostatic Hyperplasia ◽

Advanced Renal Cell Carcinoma ◽

Releasing Hormone

Patient compliance in treatment of prostate cancer with luteinizing hormone-releasing hormone (LHRH) agonist

Urology ◽

10.1016/0090-4295(93)90265-c ◽

1993 ◽

Vol 42 (5) ◽

pp. 533-535 ◽

Cited By ~ 12

Author(s):

J.Anthony Shaheen ◽

Mohammad Amin ◽

James I. Harty

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Patient Compliance ◽

Lhrh Agonist ◽

Releasing Hormone

170 Comparison of tomotherapy versus four-field pelvic box altered fractionation radiotherapy treatment plans for locally advanced squamous cell carcinoma of the cervix

Radiotherapy and Oncology ◽

10.1016/s0167-8140(06)80911-4 ◽

2006 ◽

Vol 80 ◽

pp. S49-S50

Author(s):

D. Yee ◽

R. Pearcey ◽

G. Dundas ◽

J. Hanson ◽

M. Mackenzie ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma ◽

Altered Fractionation ◽

Treatment Plans ◽

Toxicities Following Stereotactic Ablative Radiotherapy Treatment of Locally-Recurrent and Previously Irradiated Head and Neck Squamous Cell Carcinoma

Seminars in Radiation Oncology ◽

10.1016/j.semradonc.2015.11.007 ◽

2016 ◽

Vol 26 (2) ◽

pp. 112-119 ◽

Cited By ~ 8

Author(s):

Kimmen Quan ◽

Karen M. Xu ◽

Yongqian Zhang ◽

David A. Clump ◽

John C. Flickinger ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Neck Squamous Cell Carcinoma ◽

Stereotactic Ablative Radiotherapy ◽

Locally Recurrent ◽

Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix

Gynecologic Oncology ◽

10.1016/0090-8258(90)90344-k ◽

1990 ◽

Vol 37 (2) ◽

pp. 260-263 ◽

Cited By ~ 31

Author(s):

Hextan Y.S. Ngan ◽

S.Y.W. Chan ◽

L.C. Wong ◽

D.T.K. Choy ◽

H.K. Ma

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Treatment Response ◽

Squamous Cell ◽

Squamous Cell Carcinoma Antigen ◽

Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.232579499 ◽

2002 ◽

Vol 99 (23) ◽

pp. 15048-15053 ◽

Cited By ~ 27

Author(s):

J. E. Horvath ◽

A. M. Bajo ◽

A. V. Schally ◽

M. Kovacs ◽

F. Herbert ◽

...

Keyword(s):

Luteinizing Hormone ◽

Mrna Expression ◽

Term Treatment ◽

Lhrh Agonist ◽

Releasing Hormone ◽

Long Term Treatment ◽

Lhrh Antagonist

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

Human Reproduction ◽

10.1093/humrep/15.3.526 ◽

2000 ◽

Vol 15 (3) ◽

pp. 526-531 ◽

Cited By ~ 211

Author(s):

C. Albano ◽

R.E. Felberbaum ◽

J. Smitz ◽

H. Riethmüller-Winzen ◽

J. Engel ◽

...

Keyword(s):

Luteinizing Hormone ◽

Ovarian Stimulation ◽

Phase Iii ◽

Lhrh Agonist ◽

European Study ◽

Releasing Hormone ◽

Lhrh Antagonist

Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty

The Journal of Pediatrics ◽

10.1016/s0022-3476(89)80341-5 ◽

1989 ◽

Vol 115 (1) ◽

pp. 105-108 ◽

Cited By ~ 34

Author(s):

Penelope K. Manasco ◽

Ora H. Pescovitz ◽

Suvimol C. Hill ◽

Janet M. Jones ◽

Kevin M. Barnes ◽

...

Keyword(s):

Luteinizing Hormone ◽

Precocious Puberty ◽

Lhrh Agonist ◽

Releasing Hormone

Abdominal lymph node metastasis from prostatic adenocarcinoma in a patient with esophageal squamous cell carcinoma

Annals of Cancer Research and Therapy ◽

10.4993/acrt.17.29 ◽

2009 ◽

Vol 17 (1) ◽

pp. 29-31

Author(s):

Kentaro Yamaguchi ◽

Yoshihiko Naritaka ◽

Shinichi Asaka ◽

Noriyuki Isohata ◽

Takeshi Shimakawa ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Lymph Node ◽

Lymph Node Metastasis ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Prostatic Adenocarcinoma ◽

Abdominal Lymph Node ◽

Node Metastasis